José Luis Llorente

José Luis Llorente

Auto-generated profile, based on publicly available information

José Luis Llorente

Department of Otorhinolaryngology, Head and Neck Surgery, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2018 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
RCRubén Cabanillas
Rubén Cabanillas
MDMarta Diñeiro
Marta Diñeiro
GCGuadalupe A. Cifuentes
Guadalupe A. Cifuentes
DCDavid Castillo
David Castillo
PPPatricia C. Pruneda
Patricia C. Pruneda
JCJuan Cadiñanos
Juan Cadiñanos
Sensorineural hearing loss (SNHL) is the most common sensory impairment. Comprehensive next-generation sequencing (NGS) has become the standard for the etiological diagnosis of early-onset SNHL. However, accurate selection of target genomic regions (gene panel/exome/genome), analytical performance and variant interpretation remain relevant difficulties for its clinical implementation. We developed a novel NGS panel with 199 genes associated with non-syndromic and/or syndromic SNHL. We evaluated the analytical sensitivity and specificity of the panel on 1624 known single nucleotide variants (SNVs) and indels on a mixture of genomic DNA from 10 previously characterized lymphoblastoid cell lines, and analyzed 50 Spanish patients with presumed hereditary SNHL not caused by GJB2/GJB6, OTOF nor MT-RNR1 mutations. The analytical sensitivity of the test to detect SNVs and indels on the DNA mixture from the cell lines was > 99.5%, with a specificity > 99.9%. The diagnostic yield on the SNHL patients was 42% (21/50): 47.6% (10/21) with autosomal recessive inheritance pattern (BSND, CDH23, MYO15A, STRC [n = 2], USH2A [n = 3], RDX, SLC26A4); 38.1% (8/21) autosomal dominant (ACTG1 [n = 3; 2 de novo], CHD7, GATA3 [de novo], MITF, P2RX2, SOX10), and 14.3% (3/21) X-linked (COL4A5 [de novo], POU3F4, PRPS1). 46.9% of causative variants (15/32) were not in the databases. 28.6% of genetically diagnosed cases (6/21) had previously undetected syndromes (Barakat, Usher type 2A [n = 3] and Waardenburg [n = 2]). 19% of genetic diagnoses (4/21) were attributable to large deletions/duplications (STRC deletion [n = 2]; partial CDH23 duplication; RDX exon 2 deletion). In the era of precision medicine, obtaining an etiologic diagnosis of SNHL is imperative. Here, we contribute to show that, with the right methodology, NGS can be transferred to the clinical practice, boosting the yield of SNHL genetic diagnosis to 50–60% (including GJB2/GJB6 alterations), improving diagnostic/prognostic accuracy, refining genetic and reproductive counseling and revealing clinically relevant undiagnosed syndromes.

28 November 2007 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
PDF file
DLDavid Lobo
David Lobo
JLJosé L. Llorente
José L. Llorente
CSCarlos Suárez
Carlos Suárez
Objectives: This study aims to analyze the treatments, prognostic variables, and outcomes of patients with squamous cell carcinomas (SCC) of the external auditory canal (EAC) and middle ear treated in our department over a 15-year period. Design: A retrospective analysis of 19 patients treated in our department between 1990 and 2006. The patients were staged according to the Pittsburgh classification. Patients were treated with either a lateral (LTBR) or an extended temporal bone resection (total or subtotal). Parotidectomy was performed in patients with suspected clinical or radiological invasion and postoperative radiotherapy was the adjuvant treatment in most patients in advanced stages. Results: The overall 5-year survival was 37%. There were no patients in stage I. The survival rates were 100%, 25%, and 16% for stages II, III, and IV, respectively. Facial nerve paralysis (p = 0.007) and lymph node involvement (p = 0.006) were associated with decreased survival rates. Conclusion: SCC of the temporal bone are rare but have a poor prognosis. Lymph node involvement and facial nerve palsy are associated with a poorer outcome. These tumors must initially be treated radically, for which an early diagnosis is important.

11 December 2003 in Cancer
Verified
Journal Article
Closed access
PDF file
MAManuela Ariza
Manuela Ariza
JLJosé Luis Llorente
José Luis Llorente
CACesar Alvarez‐Marcas
Cesar Alvarez‐Marcas
LBLucia Baragaño
Lucia Baragaño
ASAna Salas
Ana Salas
ASAndres Sampedro
Andres Sampedro

1 September 2008 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
VGVirginia Franco Gutiérrez
Virginia Franco Gutiérrez
JPJosé Luis Llorente Pendás
José Luis Llorente Pendás
APAndrés Coca Pelaz
Andrés Coca Pelaz
RFRubén Cabanillas Farpón
Rubén Cabanillas Farpón
CNCarlos Suárez Nieto
Carlos Suárez Nieto
The aim of this study was to report our experience on the management of radiation-induced sarcomas (RISs). A retrospective study from 1994 to 2003 was done at our institution reviewing the medical records of 5 patients who had RISs. Five patients diagnosed of head and neck cancer received irradiation to treat their diseases. Later on, these patients developed new neoplasms in the irradiation fields (3 malignant fibrous histiocytoma, 1 osteosarcoma, and 1 angiosarcoma). The mean period of latency between irradiation and diagnosis of new tumors was 13 years. Early symptoms included neck or face swelling, odynophagia, or trigeminal hypoesthesia. All of the patients underwent surgical treatment. In 4 cases, regional and free flaps for head and neck reconstruction were required. Three patients also needed neoadjuvant chemotherapy. In the follow-up, 2 patients are alive and free of disease. Wide excision is the treatment of choice for RISs. Previous radiation therapy limits the dose that can be administered to the involved area, and the response rate to the chemotherapy is always poor.

1 May 2017 in Acta Otorrinolaringológica Española
Verified
Journal Article
Closed access
GGGianluigi Grilli
Gianluigi Grilli
VSVanessa Suarez
Vanessa Suarez
MMMaría Gabriela Muñoz
María Gabriela Muñoz
MCMaría Costales
María Costales
JLJosé Luis Llorente
José Luis Llorente

24 July 2013 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
JLJ. L. Llorente
J. L. Llorente
SOS. Obeso
S. Obeso
Fernando LõpezFernando Lõpez
Fernando Lõpez
JRJ. C. Rial
J. C. Rial
ACA. Coca
A. Coca
CSC. Suárez
C. Suárez